Persistent Disease is 3.5-Fold More Common Than Recurrent Disease After Initial Therapy for Differentiated Thyroid Cancer

Clinical Thyroidology, Volume 30, Issue 10, Page 447-449, October 2018.


https://ift.tt/2J124Uz